Report Thumbnail
Product Code LP0914510472J2G
Published Date 2023/2/20
English97 PagesGlobal

Global Molecular Imaging System Market Growth 2023-2029MedicalDevice_MedTech Market


Report Thumbnail
Product Code LP0914510472J2G◆The Feb 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2023/2/20
English 97 PagesGlobal

Global Molecular Imaging System Market Growth 2023-2029MedicalDevice_MedTech Market



Abstract


Summary

The molecular imaging system is a device that uses imaging to display specific molecules at the level of tissues, cells, and subcellular levels, reflects changes in molecular levels in the living state, and conducts qualitative and quantitative research on its biological behavior in imaging. Therefore, molecular imaging is the product of combining molecular biology technology with modern medical imaging. By developing new tools, reagents and methods, the molecular imaging system can detect abnormalities at the cellular and molecular levels during the disease process, and detect abnormalities before the disease has no anatomical changes. To explore the occurrence, development, and outcome of the disease, evaluate the In the curative effect, it acts as a bridge between molecular biology and clinical medicine.
LPI (LP Information)' newest research report, the “Molecular Imaging System Industry Forecast” looks at past sales and reviews total world Molecular Imaging System sales in 2022, providing a comprehensive analysis by region and market sector of projected Molecular Imaging System sales for 2023 through 2029. With Molecular Imaging System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Imaging System industry.
This Insight Report provides a comprehensive analysis of the global Molecular Imaging System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molecular Imaging System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Molecular Imaging System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Imaging System and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Imaging System.
The global Molecular Imaging System market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Molecular Imaging System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Molecular Imaging System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Molecular Imaging System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Molecular Imaging System players cover Azure Biosystems, GE Healthcare Life Sciences, Gel Company, Genomic Vision, Herolab GmbH Laborgeräte and UVP, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Imaging System market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
For Proteins
For Nucleic Acids
Other
Segmentation by application
For Medical
For Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Azure Biosystems
GE Healthcare Life Sciences
Gel Company
Genomic Vision
Herolab GmbH Laborgeräte
UVP
Key Questions Addressed in this Report
What is the 10-year outlook for the global Molecular Imaging System market?
What factors are driving Molecular Imaging System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Molecular Imaging System market opportunities vary by end market size?
How does Molecular Imaging System break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Molecular Imaging System Annual Sales 2018-2029
      • 2.1.2 World Current & Future Analysis for Molecular Imaging System by Geographic Region, 2018, 2022 & 2029
      • 2.1.3 World Current & Future Analysis for Molecular Imaging System by Country/Region, 2018, 2022 & 2029
    • 2.2 Molecular Imaging System Segment by Type
      • 2.2.1 For Proteins
      • 2.2.2 For Nucleic Acids
      • 2.2.3 Other
    • 2.3 Molecular Imaging System Sales by Type
      • 2.3.1 Global Molecular Imaging System Sales Market Share by Type (2018-2023)
      • 2.3.2 Global Molecular Imaging System Revenue and Market Share by Type (2018-2023)
      • 2.3.3 Global Molecular Imaging System Sale Price by Type (2018-2023)
    • 2.4 Molecular Imaging System Segment by Application
      • 2.4.1 For Medical
      • 2.4.2 For Research
    • 2.5 Molecular Imaging System Sales by Application
      • 2.5.1 Global Molecular Imaging System Sale Market Share by Application (2018-2023)
      • 2.5.2 Global Molecular Imaging System Revenue and Market Share by Application (2018-2023)
      • 2.5.3 Global Molecular Imaging System Sale Price by Application (2018-2023)
  • 3 Global Molecular Imaging System by Company

    • 3.1 Global Molecular Imaging System Breakdown Data by Company
      • 3.1.1 Global Molecular Imaging System Annual Sales by Company (2018-2023)
      • 3.1.2 Global Molecular Imaging System Sales Market Share by Company (2018-2023)
    • 3.2 Global Molecular Imaging System Annual Revenue by Company (2018-2023)
      • 3.2.1 Global Molecular Imaging System Revenue by Company (2018-2023)
      • 3.2.2 Global Molecular Imaging System Revenue Market Share by Company (2018-2023)
    • 3.3 Global Molecular Imaging System Sale Price by Company
    • 3.4 Key Manufacturers Molecular Imaging System Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Molecular Imaging System Product Location Distribution
      • 3.4.2 Players Molecular Imaging System Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    • 3.6 New Products and Potential Entrants
    • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Molecular Imaging System by Geographic Region

    • 4.1 World Historic Molecular Imaging System Market Size by Geographic Region (2018-2023)
      • 4.1.1 Global Molecular Imaging System Annual Sales by Geographic Region (2018-2023)
      • 4.1.2 Global Molecular Imaging System Annual Revenue by Geographic Region (2018-2023)
    • 4.2 World Historic Molecular Imaging System Market Size by Country/Region (2018-2023)
      • 4.2.1 Global Molecular Imaging System Annual Sales by Country/Region (2018-2023)
      • 4.2.2 Global Molecular Imaging System Annual Revenue by Country/Region (2018-2023)
    • 4.3 Americas Molecular Imaging System Sales Growth
    • 4.4 APAC Molecular Imaging System Sales Growth
    • 4.5 Europe Molecular Imaging System Sales Growth
    • 4.6 Middle East & Africa Molecular Imaging System Sales Growth
  • 5 Americas

    • 5.1 Americas Molecular Imaging System Sales by Country
      • 5.1.1 Americas Molecular Imaging System Sales by Country (2018-2023)
      • 5.1.2 Americas Molecular Imaging System Revenue by Country (2018-2023)
    • 5.2 Americas Molecular Imaging System Sales by Type
    • 5.3 Americas Molecular Imaging System Sales by Application
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Molecular Imaging System Sales by Region
      • 6.1.1 APAC Molecular Imaging System Sales by Region (2018-2023)
      • 6.1.2 APAC Molecular Imaging System Revenue by Region (2018-2023)
    • 6.2 APAC Molecular Imaging System Sales by Type
    • 6.3 APAC Molecular Imaging System Sales by Application
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe Molecular Imaging System by Country
      • 7.1.1 Europe Molecular Imaging System Sales by Country (2018-2023)
      • 7.1.2 Europe Molecular Imaging System Revenue by Country (2018-2023)
    • 7.2 Europe Molecular Imaging System Sales by Type
    • 7.3 Europe Molecular Imaging System Sales by Application
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Molecular Imaging System by Country
      • 8.1.1 Middle East & Africa Molecular Imaging System Sales by Country (2018-2023)
      • 8.1.2 Middle East & Africa Molecular Imaging System Revenue by Country (2018-2023)
    • 8.2 Middle East & Africa Molecular Imaging System Sales by Type
    • 8.3 Middle East & Africa Molecular Imaging System Sales by Application
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Molecular Imaging System
    • 10.3 Manufacturing Process Analysis of Molecular Imaging System
    • 10.4 Industry Chain Structure of Molecular Imaging System
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Molecular Imaging System Distributors
    • 11.3 Molecular Imaging System Customer
  • 12 World Forecast Review for Molecular Imaging System by Geographic Region

    • 12.1 Global Molecular Imaging System Market Size Forecast by Region
      • 12.1.1 Global Molecular Imaging System Forecast by Region (2024-2029)
      • 12.1.2 Global Molecular Imaging System Annual Revenue Forecast by Region (2024-2029)
    • 12.2 Americas Forecast by Country
    • 12.3 APAC Forecast by Region
    • 12.4 Europe Forecast by Country
    • 12.5 Middle East & Africa Forecast by Country
    • 12.6 Global Molecular Imaging System Forecast by Type
    • 12.7 Global Molecular Imaging System Forecast by Application
  • 13 Key Players Analysis

    • 13.1 Azure Biosystems
      • 13.1.1 Azure Biosystems Company Information
      • 13.1.2 Azure Biosystems Molecular Imaging System Product Portfolios and Specifications
      • 13.1.3 Azure Biosystems Molecular Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.1.4 Azure Biosystems Main Business Overview
      • 13.1.5 Azure Biosystems Latest Developments
    • 13.2 GE Healthcare Life Sciences
      • 13.2.1 GE Healthcare Life Sciences Company Information
      • 13.2.2 GE Healthcare Life Sciences Molecular Imaging System Product Portfolios and Specifications
      • 13.2.3 GE Healthcare Life Sciences Molecular Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.2.4 GE Healthcare Life Sciences Main Business Overview
      • 13.2.5 GE Healthcare Life Sciences Latest Developments
    • 13.3 Gel Company
      • 13.3.1 Gel Company Company Information
      • 13.3.2 Gel Company Molecular Imaging System Product Portfolios and Specifications
      • 13.3.3 Gel Company Molecular Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.3.4 Gel Company Main Business Overview
      • 13.3.5 Gel Company Latest Developments
    • 13.4 Genomic Vision
      • 13.4.1 Genomic Vision Company Information
      • 13.4.2 Genomic Vision Molecular Imaging System Product Portfolios and Specifications
      • 13.4.3 Genomic Vision Molecular Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.4.4 Genomic Vision Main Business Overview
      • 13.4.5 Genomic Vision Latest Developments
    • 13.5 Herolab GmbH Laborgeräte
      • 13.5.1 Herolab GmbH Laborgeräte Company Information
      • 13.5.2 Herolab GmbH Laborgeräte Molecular Imaging System Product Portfolios and Specifications
      • 13.5.3 Herolab GmbH Laborgeräte Molecular Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.5.4 Herolab GmbH Laborgeräte Main Business Overview
      • 13.5.5 Herolab GmbH Laborgeräte Latest Developments
    • 13.6 UVP
      • 13.6.1 UVP Company Information
      • 13.6.2 UVP Molecular Imaging System Product Portfolios and Specifications
      • 13.6.3 UVP Molecular Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.6.4 UVP Main Business Overview
      • 13.6.5 UVP Latest Developments
  • 14 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.